Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07175922
Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease
Sponsor: Vertero Therapeutics
View on ClinicalTrials.gov
Summary
This study seeks to understand the prevalence and variability of a gut bacteria gene called csgA in people with Parkinson's Disease. This understanding could inform development of potential new therapies targeting the gut in Parkinson's Disease.
Official title: Evaluation of csgA Prevalence, Gene Expression and Week-to-Week Variability in Participants With Parkinson's Disease and a History of Gastrointestinal Dysfunction
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-09-25
Completion Date
2026-03-30
Last Updated
2026-02-19
Healthy Volunteers
No
Conditions
Locations (1)
Center for Human Drug Research
Leiden, Netherlands